Author

H. Matsuoka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A. K. Bharti· 1 shared D. J. Field· 1 shared E. C. Unan· 1 shared E. J. Swayze· 1 shared E. Oki· 1 shared H. Saeki· 1 shared J. Mathew· 1 shared J. Watanabe· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. K. Bharti

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Wing musculature reconstruction in extinct flightless auks (Pinguinus and Mancalla) reveals incomplete convergence with penguins (Spheniscidae) due to differing ancestral states

J. Watanabe, D. J. Field, H. Matsuoka

bioRxiv · Jul 22, 2020Evolutionary Biology

CTDSP1 inhibitor rabeprazole regulates DNA-PKcs dependent topoisomerase I degradation and irinotecan drug resistance in colorectal cancer

H. Matsuoka, K. Ando, E. J. Swayze, E. C. Unan, J. Mathew, Q. Hu, Y. Tsuda, Y. Nakashima, H. Saeki, E. Oki, A. K. Bharti, M. Mori

This study shows that rabeprazole inhibits CTDSP1, which promotes irinotecan resistance in colorectal cancer by enhancing DNA-PKcs-mediated topoisomerase I degradation.

bioRxiv · Jan 7, 2020Cancer Biology